Lactoferrin supplement recalled due to undeclared milk allergen
My Life Inc is recalling Lactoferrin as Apolactoferrin dietary supplement capsules due to undeclared milk allergen. People with milk allergies should not consume this product.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall, which establishes a minimum severity score of 4 per rubric rules. The undeclared milk allergen poses significant risk to milk-allergic consumers; no illnesses have been reported.
Plain-English summary
My Life Inc is recalling Lactoferrin as Apolactoferrin 60 vegetarian capsules (300 mg per serving, UPC 8 50062 61315 7) because the product contains milk that is not declared on the label.
Milk is a major allergen that can cause serious allergic reactions in sensitive individuals. This product was distributed nationwide through online retailers and to consumers in South Korea. A total of 65 bottles were distributed in the United States.
Consumers who have purchased this product and have a milk allergy should stop using it immediately and consult a healthcare provider if they have consumed it. The recalled product has lot number FL2407511L19 (batch FL2407511) with expiration date 10/2027.
The recalled product
- Product
- Lactoferrin as Apolactoferrin 60 vegetarian capsules, 300 mg per serving. UPC 8 50062 61315 7. Amazon ASIN #B0DNLMBHGG.
- Manufacturer
- My Life Inc
- Category
- Drug — Dietary Supplement
- Hazard
- allergen-milk
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27